InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0001415889-24-012166 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-05-03 2024-05-01 PCVX Wassil Jim COO S - Sale $61.65 -3,000 215.5K -1% -$184.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-01 S D 1,753 $61.23 216,709 D — — (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $60.76 to $61.495. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) The Reporting Person has entered into a divorce settlement agreement with his ex-spouse (the "Settlement Agreement") pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Since the date of the Reporting Person's ownership report filed on April 19, 2024, the Reporting Person transferred 3,378 shares of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings.
2 Common Common Stock 2024-05-01 S D 1,062 $61.99 215,647 D — — (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $61.775 to $62.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2024-05-01 S D 185 $63.65 215,462 D — — (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $63.37 to $63.905. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.